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Abstract 
Background: Non-communicable diseases (NCDs) are the leading causes of death globally. Available data 
demonstrate that nearly 80% of NCD deaths occur in low- and middle-income countries. Of these deaths, an 
estimated 1.5 million, or 4% were due to cancer. In Ethiopia, data on the preparedness of health facilities to cope 
with the rising epidemic of cancer are insufficient. Therefore, this survey was aimed to assess service availability 
and readiness for cancer health care in Ethiopia.  
Methods: The data used in this study is part of the 2014 Ethiopian service provision assessment survey which was 
conducted from 10 March to 25 July, 2014. There were a total of 873 health facilities included in this particular 
study. The facility inventory questionnaire collected information on whether the providers in the facility manage 
patients with cancer. Information about the readiness of facilities to provide good-quality client services on cancer, 
including the availability of guidelines and trained staff were also collected.  
Results: Among all health facilities, 23% of health facilities offer services for cancer. Of the facilities that offer 
service for cancer, 8 % of them had guidelines for diagnosis and management of cancer at the service site during 
the survey and only 4 % of the facilities had staff reported that he/she or someone else in the facility had received 
in-service training in cancer diseases during the 24 months preceding the survey.  
Conclusions and recommendation: The findings indicate that there is a wide gap in service provision for cancer 
care and must be filled if basic standards are to be met for cancer care by the health care system. The health system 
strengthening including provision of evidence-based national guidelines, protocols or standards for managing 
cancer, training of providers and availing essential medicines are urgently needed for cancer service provision in 
Ethiopia.  [Ethiop. J. Health Dev.  2017;31(Special Issue):391-396] 
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Introduction 
Economic development and aging populations 
worldwide have led to a surge in non-communicable 
diseases, posing a shared, grave threat to health system 
sustainability (1). Non-communicable diseases (NCDs) 
are the leading causes of death globally, killing more 
people each year than all other causes combined. 
Available data demonstrate that nearly 80% of NCD 
deaths occur in low- and middle-income countries. 
Changes in the population structure and lifestyle result 
in the growing burden of chronic non communicable 
diseases like cancer, which characterize the 
epidemiological transition. The transition takes place at 
different paces in different parts of the world. The 
developed world has taken over a century to complete 
the transition, while the rapidly developing countries of 
Asia and Latin America are undergoing a swift 
transition. In contrast, many sub-Saharan African 
countries are said to be experiencing a delayed 
transition(2). Cancer is the second largest contributor 
to the non-communicable disease burden and its impact 
continues to rise (1). The burden of chronic diseases is 
increasing in low- and middle-income countries, while 
it remains stable in high-income countries. Almost 50 
% of the adult disease burden in low- and middle 
income countries is now attributable to chronic 
diseases, and about 30 % of all deaths in these 
countries occur at ages 15 to 59, compared with 15 % 
in high-income countries(3).An analysis by the 
Harvard School of Public Health and the World 
Economic Forum estimated that there were 13.3 
million new cases of cancer in 2010, with the number 
projected to rise to 21.5 million in 2030(1).For the 
prevention and control of non-communicable disease 
including cancer, the 2010 global non-communicable 
diseases capacity assessment survey report indicated 
that primary prevention and health promotion, 
detection of risk factor and disease management were 
most prevalent activities in the health care systems in 
the Western Pacific Region, South-East Asia Region 
and European Region as well as the Region of the 
Americas, with over 80% of countries providing each 
in their primary care system. Countries in the African 
Region and Eastern Mediterranean Region generally 
reported the lowest prevalence for all components and  
the global capacity assessment survey conducted in 
2013, 85% of countries reported offering risk-factor 
and disease management in their primary healthcare 
systems (4, 5).  The term cancer is used generically for 
more than 100 different diseases including malignant 
tumors of different sites (such as breast, cervix, 
prostate, stomach, colon/rectum, lung, mouth, 
leukaemia, sarcoma of bone, Hodgkin disease, and 
non-Hodgkin lymphoma). Common to all forms of the 
disease is the failure of the mechanisms that regulate 
normal cell growth, proliferation and cell death. 
Ultimately, there is progression of the resulting tumor 
from mild to severe abnormality, with invasion of 
neighboring tissues and, eventually, spread to other 
areas of the body. Cancer is and will be an increasingly 
important factor in the global burden of disease in the 
decades to come. The estimated number of new cases 
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each year is expected to rise from 10 million in 2000 to 
15 million by 2020. Some 60% of all these new cases 
will occur in the less developed parts of the world (6). 
Improved cancer control will, to a substantial degree, 
relate to prevention strategies and early detection 
programs, including information campaigns and 
population-based screening programs. Success of the 
early detection programs will rely on effective and 
optimal use of treatment possibilities (6). 
 
Cancer diagnosis is the first step to cancer 
management. This calls for a combination of careful 
clinical assessment and diagnostic investigations 
including endoscopy, imaging, histopathology, 
cytology and laboratory studies. Once a diagnosis is 
confirmed, it is necessary to ascertain cancer staging, 
where the main goals are to aid in the choice of 
therapy, prognostication, and to standardize the design 
of research treatment protocols. The primary objectives 
of cancer treatment are cure, prolongation of life, and 
improvement of the quality of life. A national cancer 
control programme should therefore establish 
guidelines for integrating treatment resources with 
programmes for early detection, and provide 
therapeutic standards for the most important cancers in 
the country. Care of cancer patients typically starts 
with recognition of an abnormality, followed by 
consultation at a health care facility with appropriate 
services for diagnosis and treatment. Treatment may 
involve surgery, radiation therapy, chemotherapy, 
hormonal therapy, or some combination of these. An 
initial priority, especially in developing countries, 
should be the development of national diagnostic and 
treatment guidelines to establish a minimum standard 
of care, and promote the rational use of existing 
resources and greater equity in access to treatment 
services. Optimal treatment of people diagnosed with 
certain types of cancer detected early, for example, 
cancers of the uterine cervix and corpus, breast, testis, 
and melanoma, will result in 5-year survival rates of 
75% or more. By contrast, survival rates in patients 
with cancer of the pancreas, liver, stomach, and lung 
are generally less than 15%. Some treatments require 
sophisticated technology that is available only in 
locations with substantial resources. Since the cost of 
establishing and maintaining such facilities is high, it is 
desirable that they should initially be concentrated in 
relatively few places in a country to avoid draining 
resources that could be devoted to other aspects of the 
national cancer control programme. Facilities can be 
expanded when additional resources are available. The 
majority of cancer patients in developing countries are 
diagnosed at advanced stages of the disease, because of 
the lack of awareness of the need for rapid action if a 
cancer symptom or sign is detected, the lack of early 
detection programmes, and the limited resources for 
diagnosis and treatment (6). 
 
Cancer care is now responsible for 5–7 % of healthcare 
costs in high-income countries, reaching approximately 
$290 billion per year in 20102 worldwide spending on 
cancer is equivalent to the GDP of Hong Kong, the 
35th largest economy in the world. For many health 
economies, cancer is one of the three largest areas of 
medical spending(7, 8).Today there is an expectation in 
many health economies that the costs of cancer will 
rise dramatically.  Much of the success in slowing the 
number of predicted cancer deaths in the developed 
world has resulted from prevention and screening 
efforts over the last 30 years. Smoking cessation and 
tobacco control, breast cancer screening, and colorectal 
cancer screening have all saved lives. In the US, it is 
estimated that over one million cancer deaths were 
averted, through a combination of prevention (thought 
to be entirely responsible for the decline in lung cancer 
death rates), early detection, and improvements in 
treatment, as deaths increased less quickly in the 
1990s(9). The set of contextual circumstances arising 
from the reforms, combined with the lack of resources 
to provide any ‘headspace’  for cancer were seen as 
hampering efforts to develop services and improve 
performance in Ethiopia . Where the incidence of 
cancer justifies it, and the necessary resources can be 
made available, providing screening services for 
cancers is recommended. This is feasible mainly in 
medium and high-resource level countries. Screening 
for other cancer sites must be regarded as experimental 
and cannot be recommended at present as public health 
policy (10). The ministry of health Ethiopia targeted to 
launch HPV vaccination demonstration program, and 
achieve at least 80 percent coverage of girls within the 
target population, disseminate the National Cancer-
Control Plan, Open 58 “Screen-and-Treat” sites and 
reach at least 80 percent coverage of the appropriate 
target populations with screening and treatment for pre-
invasive cervical-cancer cases (11). 
 
Methods  
Study setting:  In Ethiopia, the health sector has 
recently introduced a three-tier health care delivery 
system: level one is a Woreda/District health system 
comprised of a primary hospital, health centres  and 
their satellite Health Posts  connected to each other by 
a referral system(12). A total of 23,144 functional and 
formal sector health facilities are available in Ethiopia 
which included: 214 hospitals, 3,317 health centres, 15, 
525 health posts, and 4,088 private clinics. Information 
on cancer service was collected from a representative 
sample of higher level health facilities (hospitals, 
health centres and private clinics) across the country. 
 
Data Sources:  The data used in this study were part of 
the 2014 Ethiopian service provision assessment 
Survey (SPA). The sample for the survey was a 
stratified random sample designed to provide 
representative results for Ethiopia, for different facility 
types and different management authorities, and for 
each of the 11 administrative regions of the country. 
The sample size determination has been achieved by 
controlling the survey precision at region level and by 
facility type at national level. The data are nationally 
and sub-nationally representative and internationally 
comparable. As described in table 1, there were a total 
of 873 health facilities included in this analysis. 
 
Measurement:  Data were collected using a facility 
inventory questionnaire (13, 14) which was used to 
obtain information on how the facilities are prepared to 
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provide services for cancer. Cancer services were 
deemed to be available when the providers in the 
facility diagnose, prescribe treatment for, or manage 
patients with cancer. The facility inventory 
questionnaire collected information on the availability 
of specific items, components of logistics support 
systems, and facility infrastructure, including the 
service delivery environment. After obtaining consent 
from the authorities of each health facility, the most 
knowledgeable provider of services to cancer was 
interviewed by the data collectors. The two key areas 
related to the provision of cancer services at the 
assessed health facilities comprised of the following: 
Availability of services and service readiness which 
addresses the readiness of facilities to provide good-
quality client services for cancer, including the 
availability of guidelines, trained staff, equipment, and 
essential medicines. The indicators presented in this 
table 2 comprise the staff, training and equipment 
domains to assess readiness of health facility to provide 
services for cancer diseases within the health facility 
assessment methodology proposed by WHO and 
USAID (2012) 
Data management and Analysis:  The process of 
inspecting, cleaning, and exporting data was done 
using CSPro software package. Descriptive analysis 
was performed using CSPro tabulation. The analyses 
considered only those items readily available and 




Overview of health facilities IB:  Table 1 presents the 
percent distribution by background characteristics of 
the facilities that assessed provision of cancer services. 
The result included findings on cancer for a total of 
873 health facilities (214 Hospitals, randomly selected 
292 health centres, and 367 clinics) all over the 
country. Over half (51%) of all the health facilities in 
this analyses were public, and 45 % were private for-
profit health facilities. More than six in ten (61.6%) of 
facilities visited were from urban area. Hospitals 
constituted 24.6%, health centres making the largest 
proportion at 33.4% of all facilities, lower clinics 
20.4% while medium clinics 15.1% of the total health 
facilities visited (Table1). 
 
Table 1: Total number of health facilities assessed by type of facilities 
Facility type Weighed  Unweighed % 








2 32 0 31 0 0 1 
General 
hospital 
7 130 1 71 1 51 7 
Primary 
hospital 
3 52 0 44 1 4 3 
Health center 182 292 16 290 0 0 2 
Higher clinic 13 57 1 0 0 55 2 
Medium clinic 37 132 3 0 4 121 7 
Lower clinic 119 178 10 1 3 165 9 
National 363 873 100 437 9 396 31 
 
Availability of services for cancer:  Services were 
deemed to be available when the providers in the 
facility diagnose, prescribe treatment for, or manage 
patients with cancer. Among all health facilities that 
offer services for non-communicable diseases, 23 % of 
the facilities reported that providers in the facility 
diagnose, prescribe treatment for, or manage patients 
with cancer diseases. Of them 20 % of the facilities 
reported that providers in the facility only diagnose 
patients with cancer diseases. Treatment services for 
cancer are non-existent (0%) throughout all the facility 
types except primary hospitals in which 2% of facilities 
reported to give treatment services for cancer. The 
services for cancer were more likely available in 
hospitals and higher clinics (ranging from 60% to 69%) 
than other facility types (in lower clinics only 3%). 
 
Readiness to provide quality cancer diseases services: 
Among the facilities that offer service for cancer, 7 % 
had guidelines for diagnosis and management of cancer 
at the service site during the survey. This proportion 
ranges from 18% for referral hospital to 0 % for lower 
clinics (Table 2). Among all facilities that offer 
services for cancer, only 4 % had someone in the 
facility who had received in-service training in cancer 
diseases during the 24 months preceding the survey. 
However, in primary hospitals and lower clinics none 
of the staff had received in-service training in cancer 
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Table 2:  Services provided for cancer diseases and availability of guidelines and trained staff among the 
facilities offering services for cancer diseases, Ethiopia SPA 2014 




































Facility type        
Referral 
Hospital  
69 44 0 2 18 14 1 
General 
Hospital  
66 40 0 7 12 13 5 
Primary 
Hospital  
65 54 2 3 12 0 2 
Health Centre  28 26 0 182 5 3 51 
Higher Clinic  60 48 0 13 11 6 8 
Medium Clinic  32 29 0 37 11 5 12 
Lower Clinic  3 3 0 119 0 0 4 
Managing 
authority 
       
Government  29 26 1 190 6 3 55 
Private for 
profit  
15 13 0 163 10 6 25 
NGO  19 16 0 8 8 0 1 
Region        
Tigray  25 20 0 22 15 11 5 
Afar  4 4 0 5 33 0 0 
Amhara  24 22 0 87 12 0 21 
Oromia  17 16 0 116 2 7 20 
Somali  30 22 0 8 0 0 2 
Benishangul 
Gumuz  
14 9 0 4 0 11 0 
SNNP  23 21 1 80 3 3 19 
Gambella  2 2 0 6 0 0 0 
Harari  63 51 0 2 5 5 1 
Addis Ababa  36 29 1 31 11 4 11 
Dire Dawa  62 56 0 3 10 0 2 
Urban/rural        
Urban  28 23 0 149 10 3 41 
Rural  19 18 0 214 4 5 41 
Total 23 20 0 363 7 4 82 
1 Providers in the facility diagnose, prescribe treatment for, or manage patients with cancer diseases. 
 2 The respondent reported that he/she or someone else in the facility had received in service training in cancer 
diseases during the 24 months preceding the survey. The training must have involved structured sessions; it does 
not include individual instruction that a provider might have received during routine supervision. 
 
Discussion   
According to WHO(15), cancer diagnosis and 
treatment service is fundamental to the optimum 
management of cancer patients, and provision of these 
services is central to national cancer control strategies. 
Although it requires long term planning and 
appropriate assessment of health care resources, 
without recourse to sophisticated technologies, 
effective treatment services for many cancers can be 
comprehensively provided at moderate cost. Studies 
indicated that around 85% of the world’s population 
lives in developing countries, but are served by only 
approximately 30% of the world’s treatment facilities 
for cancer care. Conversely, the developed countries, 
with 15% of the world’s population, have 70% of these 
facilities. Approximately 30 countries (15 countries in 
Africa as well as several in Asia) do not have even one 
radiation therapy machine(16). However, availability 
alone does not determine access to the service. 
Geographical or spatial accessibility and affordability 
by patients and their families to cover the direct and 
indirect cost of the treatments are also barriers to 
access. Another component of access is awareness  not 
only the patients must be aware of the existence of 
treatment and its benefits, but their treating physicians 
must be aware of the availability and indications for 
cancer care(17). Despite the high burden of mortality 
and morbidity from cancer in Ethiopia, the responses to 
the disease in Ethiopia have not been comprehensive 
enough as it should be. The result presented in this 
study indicates insufficient availabilities of cancer 
services, guidelines for diagnosis and management of 
cancer and trained staff. However, as compared to 
other countries, the findings indicated that those 
facilities offering cancer diagnosis and/or management 
services in Ethiopia were higher than reports from 
surveys of other African countries, i.e. 8% in Tanzania 
where cervical cancer screening is available in only 8% 
of facilities (18). But it is much more lower than 
facilities in Zambia where half (53%) of facilities 
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offered breast cancer screening services (19). A 
number of perceived challenges facing cancer services 
were repeatedly found throughout countries (20-23). 
These included: rising demand for services and a lack 
of capacity to respond to this rising demand, the loss of 
national and local leadership and infrastructure, 
fragmentation of commissioning across the patient 
pathway; variation in the roles and responsibilities of 
new organizations and the need to rebuild relationships 
and regain expertise across the new architecture (20). 
The findings represent a move away from a model of 
care that traditionally centered at Black lion Hospital. 
The evidence suggests that this does not work, and that 
we need to explore innovative ways of delivering 
services to each and meet the distinct needs of the 
Ethiopian population, including through collaboration 
across individuals, groups, services and organizations. 
We must continue to ask ourselves: “how can we do 
better to address all the population. In addition a 
national framework is necessary to ensure consistent 
and cohesive care is provided to the relatively small 
numbers of patients diagnosed with cancer who are 
widely spread across the country. 
 
Conclusion: 
The finding depicts a wide gap and must be filled if 
basic standards are to be met for cancer care by the 
health care system. As we have seen, many health 
systems will struggle to provide quality cancer care if 
the dynamics we have described continue to put more 
demand on a system which is already strained. Failing 
to address cancer care demand could lead to a variety 
of undesirable system-level poor outcomes. The health 
system strengthening including provision of evidence-
based national guidelines, protocols or standards for 
managing cancer, training of providers and availing 
essential medicines are urgently needed for cancer 
service provision in Ethiopia. 
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